Fitch: Teva Remains on Watch Negative on Allergan Generics Acquisition
Business Wire - 6 mins ago
According to Fitch Ratings, the ratings of Teva Pharmaceutical Industries Limited (NYSE: TEVA) and its subsidiaries, including the 'BBB+' long-term Issuer Default Rating, remain on Rating Watch Negative, following its announcement that it will acquire the global generics business of Allergan plc (Allergan; NYSE: AGN) for $40.5 billion.
AGN: 337.53 (+10.55), TEVA: 70.95 (-1.05)
Stocks In Rebound Mode; Icon, Cadence Break Out
at Investor's Business Daily - 1 hr 1 min ago
Stocks stepped up rebound efforts and hit fresh session highs Tuesday afternoon. The major averages have recouped more than half of Monday's steep losses amid more earnings reports and mixed economic data. The S&P 500 led the pack with a 1% gain. On...
AGN: 337.53 (+10.55), BIDU: 164.64 (-33.04), MYL: 55.69 (-0.68), CDNS: 21.00 (+2.03), TEVA: 70.95 (-1.05), ICLR: 74.43 (+9.48)
Israel ETFs Surge on Teva Megamerger Deal - ETF News And Commentary
Sweta Killa - Zacks Investment Research - Tue Jul 28, 9:50AM CDT
The takeover deal of Allergan by Teva has led to a surge in Israel ETFs.
IHE: 181.70 (+2.81), AGN: 337.53 (+10.55), PPH: 73.81 (+0.62), EIS: 55.50 (+0.58), ISRA: 33.98 (+0.23), TEVA: 70.95 (-1.05)
Hikma Pharmaceuticals to Buy Generic Drug Maker Roxane for $2.65 Billion
at The Street - Tue Jul 28, 9:46AM CDT
Jordan's Hikma Pharmceuticals is set to become the sixth-largest U.S. generic drug maker after an agreement to buy Boehringer Ingelheim's Columbus, Ohio-based Roxane Laboratories for about $2.65 billion.
AGN: 337.53 (+10.55), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)
Teva Pharmaceutical Industries Up 15.4% Since SmarTrend Uptrend Call (TEVA)
Comtex SmarTrend(R) - Tue Jul 28, 9:43AM CDT
SmarTrend identified an Uptrend for Teva Pharmaceutical Industries (NASDAQ:TEVA) on July 9th, 2015 at $62.20. In approximately 3 weeks, Teva Pharmaceutical Industries has returned 15.42% as of today's recent price of $71.79.
TEVA: 70.95 (-1.05)
Will Teva Pharmaceutical (TEVA) Stock Rise Following BMO Capital Upgrade?
at The Street - Tue Jul 28, 9:39AM CDT
Teva Pharmaceutical (TEVA) had its rating increased to 'outperform' from 'market perform' at BMO Capital Markets this morning.
TEVA: 70.95 (-1.05)
Critical Alerts For ConocoPhillips, Teva, Pfizer Inc., Twitter and Invensense Released By InvestorsObserver
PR Newswire - Tue Jul 28, 8:31AM CDT
InvestorsObserver issues critical PriceWatch Alerts for COP, TEVA, PFE, TWTR and INVN.
PFE: 35.26 (+0.92), INVN: 13.54 (+0.65), COP: 52.86 (+2.21), TEVA: 70.95 (-1.05), TWTR: 36.27 (+1.57)
Watching Twitter for Moves at Teva and Biogen
at The Street - Tue Jul 28, 7:28AM CDT
Twitter sentiment predicts the big moves in two healthcare stocks-NYMX and BIIB.
BIIB: 317.62 (+8.19), TEVA: 70.95 (-1.05)
Teva Announces European Medicines Agency (EMA) Confirms Successful Validation of Reslizumab Marketing Authorization Application
Business Wire - Tue Jul 28, 7:00AM CDT
Teva Pharmaceutical Industries Ltd., (NYSE:TEVA) today announced that it has successfully filed a Marketing Authorization Application (MAA) with the European Medicines Agency (EMA) for reslizumab. Reslizumab is a humanized anti-interleukin-5 (IL-5) monoclonal antibody (mAb) for the treatment of inadequately controlled asthma in adult patients with elevated blood eosinophils, despite an inhaled corticosteroid (ICS)-based regimen.
TEVA: 70.95 (-1.05)
Health Care & Industrials: Two ETFs Trading with Outsized Volume - ETF News And Commentary
Zacks Equity Research - Zacks Investment Research - Tue Jul 28, 5:00AM CDT
Heavier-than-normal volume put these health care and industrial ETFs in focus.
AGN: 337.53 (+10.55), SPY: 209.46 (+2.67), IYH: 161.82 (+2.60), QQQ: 111.32 (+1.14), DIA: 176.22 (+1.99), TEVA: 70.95 (-1.05), VIS: 103.43 (+1.91)
Business Highlights
By The Associated Press - AP - Mon Jul 27, 5:12PM CDT
___
AGN: 337.53 (+10.55), QSR: 42.64 (+1.14), F: 14.88 (+0.33), QSR.TO: 55.09 (+0.88), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05), MHFI: 98.44 (-1.15)
Mylan Shares Tank After Teva Pharmaceutical Nixes Takeover Bid
at The Street - Mon Jul 27, 4:47PM CDT
Pharmaceutical giant Mylan (MYL) was the worst performing stock in the S&P 500 on Monday, making it TheStreet's Move of the Day.
AGN: 337.53 (+10.55), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)
Look for Shares of Teva Pharmaceutical Industries to Potentially Pullback after Yesterday's 16.41% Rise
Comtex SmarTrend(R) - Mon Jul 27, 3:43PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $66.61 to a high of $72.15. Yesterday, the shares gained 16.4%, which took the trading range above the 3-day high of $63.36 on volume of 39.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TEVA: 70.95 (-1.05)
After Yesterday's Rally of 16.41% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Mon Jul 27, 3:42PM CDT
Teva Pharmaceutical Industries (NASDAQ:TEVA) traded in a range yesterday that spanned from a low of $66.61 to a high of $72.15. Yesterday, the shares gained 16.4%, which took the trading range above the 3-day high of $63.36 on volume of 39.5 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
TEVA: 70.95 (-1.05)
Analysts expect more tie-ups in generic drug business
AP - Mon Jul 27, 3:43PM CDT
NEW YORK (AP) — Analysts say they expect more tie-ups are coming in the generic drug industry in the wake of Teva's mammoth deal for the generic drug business of Allergan.
1 Comment
IPXL: 49.13 (-0.12), AGN: 337.53 (+10.55), AKRX: 46.81 (+0.65), SGNT: 25.43 (-0.05), MYL: 55.69 (-0.68), TEVA: 70.95 (-1.05)
Stocks Fall For Fifth Straight Session On China Woes
at Investor's Business Daily - Mon Jul 27, 3:39PM CDT
Stocks fell for the fifth straight session Monday as a sell-off in China's main index sparked fears of a slowdown in the world's second-biggest economy. The Nasdaq fell 1%, sliding below its 50-day moving average. The Dow Jones industrial average...
AGN: 337.53 (+10.55), NFX: 31.59 (+0.71), CYBR: 60.25 (+0.42), SOHU: 43.97 (+1.23), TEVA: 70.95 (-1.05), MRO: 21.51 (+0.82), JD: 32.40 (+0.25), PAYC: 31.41 (-0.19), BABA: 80.51 (-0.89)
Cramer -- Twitter Has Short-Term Problems; Gilead's 'Problem' Is Too Much Cash
at The Street - Mon Jul 27, 3:30PM CDT
People are "max negative" on Twitter ahead of its earnings report Tuesday, which Jim Cramer doesn't see as unjustified -- at least, in the short term.
AGN: 337.53 (+10.55), BIIB: 317.62 (+8.19), GILD: 112.96 (+2.42), TEVA: 70.95 (-1.05), TWTR: 36.28 (+1.58)
Teva and Restaurant Brands are big market movers
AP - Mon Jul 27, 3:25PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily Monday on the New York Stock Exchange and the Nasdaq Stock Market:
QSR: 42.64 (+1.14), QSR.TO: 55.09 (+0.88), RJET: 3.19 (-0.58), MYL: 55.69 (-0.68), BECN: 33.21 (+0.51), TEVA: 70.95 (-1.05), WAB: 99.20 (+1.27)